When clinical trial participants are so happy with the product that they refuse to give it back at the end of the study, interest cannot help but be piqued. A pilot study of castor oil as a blepharitis treatment, conducted by University of Auckland’s Ocular Surface Laboratory (OSL), was one such example.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
